Literature DB >> 2296622

Electroconvulsive treatment attenuates behavioral response to SKF 38393 in reserpine-treated mice.

X Z Hao1, A A Mathé, J M Mathé, T H Svensson.   

Abstract

Electroconvulsive treatment (ECT) of mice, once daily for 7 days, significantly reduced the stimulation of motor activity induced by the selective dopamine (DA) D1-receptor agonist SKF 38393 (15 mg/kg IP), but significantly increased the motor stimulation by the unselective DA-receptor agonist apomorphine (1.5 mg/kg IP) in reserpine-treated (10 mg/kg IP) mice, when compared to control mice, receiving sham ECT. The results provide a functional correlate to previously observed ECT-induced down-regulation of D1 receptor sites in DA-rich regions of the rodent brain. Such an effect may be significant for clinical actions of ECT in affective disorders and, possibly, in Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2296622     DOI: 10.1007/bf02245805

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  13 in total

1.  Effect of electroconvulsive shock on monoaminergic receptor binding sites in rat brain.

Authors:  D A Bergstrom; K J Kellar
Journal:  Nature       Date:  1979-03-29       Impact factor: 49.962

2.  Electroconvulsive shock and postsynaptic catecholamine effects: increased psychomotor stimulant action of apomorphine and clonidine in reserpine pretreated mice by repeated ECS.

Authors:  K Modigh
Journal:  J Neural Transm       Date:  1975       Impact factor: 3.575

3.  Further observations on the effect of repeated electroconvulsive shock on the behavioural responses of rats produced by increases in the functional activity of brain 5-hydroxytryptamine and dopamine.

Authors:  A R Green; D J Heal; D G Grahame-Smith
Journal:  Psychopharmacology (Berl)       Date:  1977-04-29       Impact factor: 4.530

4.  Electroconvulsive shock increases the behavioural responses of rats to brain 5-hydroxytryptamine accumulation and central nervous system stimulant drugs.

Authors:  J P Evans; D G Grahame-Smith; A R Green; A F Tordoff
Journal:  Br J Pharmacol       Date:  1976-02       Impact factor: 8.739

5.  Enhanced stereotypies after repeated injections but not continuous amphetamines.

Authors:  L R Nelson; G Ellison
Journal:  Neuropharmacology       Date:  1978-12       Impact factor: 5.250

Review 6.  The mechanism of action of antidepressant treatments: basic aspects.

Authors:  A R Green
Journal:  Pharmacopsychiatry       Date:  1988-01       Impact factor: 5.788

Review 7.  D1 dopamine receptor--the search for a function: a critical evaluation of the D1/D2 dopamine receptor classification and its functional implications.

Authors:  D Clark; F J White
Journal:  Synapse       Date:  1987       Impact factor: 2.562

8.  Electroconvulsive therapy in Parkinson's syndrome with "on-off" phenomenon.

Authors:  J Balldin; S Edén; A K Granérus; K Modigh; A Svanborg; J Wålinder; L Wallin
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

9.  Modulation of dopamine-mediated behavioural responses by antidepressants: effects of single and repeated treatment.

Authors:  A Delini-Stula; A Vassout
Journal:  Eur J Pharmacol       Date:  1979-10-15       Impact factor: 4.432

10.  The D1 dopamine receptor antagonist SCH 23390 increases cocaine self-administration in the rat.

Authors:  G F Koob; H T Le; I Creese
Journal:  Neurosci Lett       Date:  1987-08-31       Impact factor: 3.046

View more
  1 in total

1.  MK-801 prevents the enhanced behavioural response to apomorphine elicited by repeated electroconvulsive treatment in mice.

Authors:  G G Nomikos; A A Mathé; J M Mathé; T H Svensson
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.